United States · Bill · HR
H.R. 1629 (118th)
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
Introduced
17 March 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
11 June 2024
Summary
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 17 March 2023
Introduced in House (PDF)
Introduced in House · EN · 17 March 2023
Introduced in House
summary · EN · 17 March 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/1629
- Open data entity: https://api.congress.gov/v3/bill/118/hr/1629